Entries by Marketing Team

Asceneuron secures $100m Series C financing to progress neurodegeneration research, Novo Holding leads round with participation from existing investor Sofinnova Partners

/in

On Tuesday, Asceneuron, a clinical stage biotech company developing small molecules targeting tau protein aggregation a driver of neurodegenerative disease, announced it had secured a $100 million Series C Financing that was led by Novo Holdings. This financing will be used to advance Asceneuron’s lead asset ASN51 into Phase 2 clinical development for the treatment […]

Novo Holdings co-leads £90 million ($114 million) Series A financing for Myricx Bio to advance a novel payload class for antibody-drug conjugates

/in

Novo Holdings, a leading life science investor, on Monday announced that it has co-led a £90 million ($114 million) Series A financing for Myricx Bio, the largest European biotech Series A financing this year. Myricx Bio is a UK biotech company focusing on the discovery and development of a novel payload class for antibody-drug conjugates […]

Novo Holdings invests in MATR Foods’ expansion within plant-based fungi food

/in

Novo Holdings on Monday announced an initial investment in Danish food-tech start-up MATR Foods (‘MATR’) to support the scaling-up of its production of sustainable meat alternatives. Established in Copenhagen in 2021, MATR specialises in developing organic innovative plant-based meat alternatives using traditional fungal fermentation techniques. Locally sourced organic ingredients like oats, split peas, lupins, beetroots, […]

Optimum’s weekly round-up: From an investment in AI-based solutions for sustainable agriculture to new data from hepatocellular carcinoma therapy!

/in

Congratulations to Verona Pharma following the US FDA’s approval of Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. Optimum is proud to have worked with the fantastic Verona Pharma team in its journey to getting to this  approval for Ohtuvayre, the first inhaled product with a novel mechanism […]

Death cap poison: the latest weapon in the fight against cancer

/in

The death cap mushroom is feared throughout much of the world because of the deadly toxin it contains, amanitin. But could the poison reputedly used by Agrippina to murder her husband, the Roman emperor Claudius, be used to destroy cancer, asks Richard Staines. Known to modern science as an inhibitor of RNA polymerase II, alpha-Amanitin […]

© Optimum Strategic Communications.